+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Daiichi Sankyo Co Ltd - logo

Daiichi Sankyo is a global pharmaceutical company and one of the largest pharmaceutical company in Japan. The company offers therapies in the areas of hypertension, dyslipidemia, diabetes, acute coronary syndrome, metastatic melanoma, cardiology, oncology, pain, and others. Formerly known as Sankyo Pharma, it changed its name to Daiichi Sankyo in April 2006. The company was founded in 1996 and is based in Parsippany, New Jersey.

Mantle Cell Lymphoma Therapeutics Market Report 2026 - Product Thumbnail Image

Mantle Cell Lymphoma Therapeutics Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Follicular Lymphoma Treatment Market Report 2026 - Product Thumbnail Image

Follicular Lymphoma Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035 - Product Thumbnail Image

Asia Pacific Alzheimer's Diagnosis and Treatment Market Outlook to 2035

  • Report
  • February 2023
  • 243 Pages
  • Asia Pacific
From
From
From
From
From
From
From
Multiple Myeloma Drugs Market Report 2026 - Product Thumbnail Image

Multiple Myeloma Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Myelodysplastic Syndrome Market Report 2026 - Product Thumbnail Image

Myelodysplastic Syndrome Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Malignant Melanoma Treatment Market Report 2026 - Product Thumbnail Image

Malignant Melanoma Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025 - Product Thumbnail Image

PD-1 Non-Small Cell Lung Cancer (PD-1+ NSCLC) - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
From
Loading Indicator